leadf
logo-loader
ASX:PXS PINK:PXSLY

Pharmaxis Ltd

Receive alerts
Market:
ASX
Market Cap:
$35.72 m
Price
0.09 AUD
Change
2.27%
52 weeks high
0.29
52 weeks low
0.05

In brief

Pharmaxis Ltd (ASX:PXS) is an Australian pharmaceutical research company with expertise in developing drugs for inflammatory and fibrotic diseases and focussed on myelofibrosis.

Snapshot

The company expects to announce receipt of milestone payments and the start of sales from its Bronchitol treatment in the near-term.